Novo Nordisk the Danish pharmaceutical firm that makes Ozempic and Wegovy said its products should only be used for FDA-approved means
The combination of GHK-Cus gene-regulatory effects with microneedlings physical collagen induction produces a result that justifies the layered approach
Schisano B, Harte AL, Lois K, Saravanan P, Al-Daghri N, Al-Attas O, Knudsen LB, McTernan PG, Ceriello A, Tripathi G
They refer to the sagging skin or loss of volume in the face or buttocks that can occur with rapid weight loss
Whether you are on one of the GLP-1 medications or not, these recipes can help support your blood sugar levels with a focus on lean proteins, high-fiber foods, and antioxidant-rich ingredients
Research has identified these alarming vision-related risks associated with GLP-1 medications: Sudden irreversible vision loss: NAION strikes without warning, often discovered upon waking, causing blurry or dim vision that progresses to immediate and permanent partial or complete blindness in the affected eye with no possibility of restoration Elevated risk across multiple studies: Beyond the Harvard findings showing 4-7 fold increased risk, a University of Southern Denmark study examining over 424,000 patients found weekly semaglutide users faced 2.19 times higher NAION risk European regulatory recognition: In June 2025, the European Medicines Agency officially recognized NAION as a possible side effect of semaglutide medications, marking formal acknowledgment by international regulators Complete absence of treatment options: Medical science currently offers no cure, no effective treatment, and no way to reverse NAION-related vision damage, leaving patients with permanent disability The permanent and irreversible nature of NAION-related optic nerve damage distinguishes these injuries from other complications that may resolve after discontinuing medication
